Showing results (1591-1600 of 1,628) with videos related to
Sort By:
Pageof 163
Cell Host & Microbe|May 2, 2023
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancerShan-Shan Jiang, Yi-Le Xie, Xiu-Ying Xiao, et al.Journal of Translational Medicine|November 18, 2023
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosisPanpan Tai, Xinyu Chen, Guihua Jia, et al.Molecular Cell|November 11, 2023
K6-linked ubiquitylation marks formaldehyde-induced RNA-protein crosslinks for resolutionAldwin Suryo Rahmanto, Christian J Blum, Claudia Scalera, et al.Frontiers in Microbiology|October 28, 2021
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut MicrobiotaSijia Li, Siyuan Yang, Yuzheng Zhou, et al.Nature Medicine|August 29, 2018
Regional variation limits applications of healthy gut microbiome reference ranges and disease modelsYan He, Wei Wu, Hui-Min Zheng, et al.Cell Reports. Medicine|August 12, 2025
Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-Year follow-up of a randomized clinical trialYong-Jie Tan, Tian-Hui Zou, Ke Yu, et al.Nature Microbiology|August 21, 2024
The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesisLu Zhang, Xiao-Xu Leng, Jianxun Qi, et al.Med (New York, N.Y.)|March 28, 2026
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapyHailong Liu, Yu Su, Jiao Zhang, et al.Microbiome|September 26, 2018
Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysisYan He, Wei Wu, Shan Wu, et al.Nature Medicine|September 26, 2018
Author Correction: Regional variation limits applications of healthy gut microbiome reference ranges and disease modelsYan He, Wei Wu, Hui-Min Zheng, et al.Pageof 163